RYE, N.Y., Oct. 19, 2015 /PRNewswire/ -- Curemark, a drug research and development company focused on the treatment of neurological diseases for unmet medical needs, announced today that CEO and Founder, Dr. Joan Fallon, will be speaking at the following upcoming scientific conferences:
About Curemark, LLC
Curemark, LLC is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological disorders. Curemark's pipeline includes preclinical and clinical-stage programs for the treatment of Autism, ADHD, addiction, Schizophrenia and Parkinson's disease. For additional information, please visit our website at http://www.curemark.com or follow @curemark on Twitter.
Logo - http://photos.prnewswire.com/prnh/20150922/269120LOGO
SOURCE Curemark
Share this article